Prescriber Scope of Practice for Depression in Texas

If you’re a psychiatrist or PMHNP treating depression, you’ve probably asked yourself: Can I prescribe antidepressants—or stimulants, benzos, even Adderall—through a video call? What about patients I’ve never met in person?

The short answer in 2025: Yes. But the rules are evolving, and the details matter—especially if you’re prescribing controlled substances or practicing across state lines.

Here’s what you need to know to stay compliant, protect your patients, and build a sustainable telehealth practice treating depression.

The Federal Picture: DEA Rules on Telehealth Prescribing (2025–2026)

COVID-Era Flexibility Extended Through December 2026

During the pandemic, the DEA waived the Ryan Haight Act’s in-person exam requirement, allowing providers to prescribe controlled substances via telehealth to new patients. That flexibility was set to expire multiple times—but as of January 2026, the DEA and HHS extended it through December 31, 2026.

What this means for you:

• You can initiate treatment for a new patient via video—no prior in-person visit required—and prescribe Schedule II–V controlled substances if medically appropriate.
• This applies nationwide and covers psychiatric conditions like depression, anxiety, ADHD, and insomnia.
• Standard of care still applies: thorough evaluation, documentation, PDMP checks, appropriate diagnosis.

Example: A patient contacts you via telehealth with treatment-resistant depression and co-occurring ADHD. After a comprehensive video evaluation, you can prescribe an SSRI and Adderall (Schedule II) to start treatment—legally, under current DEA rules.

What Happens After 2026? DEA’s Permanent Rulemaking

The DEA is finalizing permanent telehealth prescribing rules. In January 2025, they proposed:

1. Special Registration for Telemedicine: Providers prescribing Schedule III–V controlled substances via telehealth would apply for a special DEA registration.

2. Advanced Telemedicine Registration (Schedule II): Only board-certified psychiatrists, hospice/palliative care physicians, nursing home physicians, and certain pediatric specialists could prescribe Schedule II drugs (like stimulants) via telehealth without an in-person visit.

3. Buprenorphine Grace Period: For opioid use disorder, patients can receive buprenorphine via telehealth for up to 180 days before an in-person visit is required.

4. Platform Registration: Telehealth companies prescribing controlled substances must register with the DEA and meet reporting standards—aimed at preventing ‘pill mill’ abuses.

What this means for psychiatrists:If these rules are finalized as proposed, you’ll likely be able to continue tele-prescribing stimulants and other Schedule II meds for psychiatric conditions—but you’ll need to obtain the special registration. PMHNPs and other non-MD providers may face tighter restrictions on Schedule II teleprescribing.

Bottom line: The regulatory environment is moving toward permanent telehealth flexibility for psychiatry, with some guardrails. But for now, through 2026, you’re operating under the most permissive rules we’ve had.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Depression Medications: Controlled vs Non-Controlled

Most first-line depression medications—SSRIs, SNRIs, bupropion, mirtazapine—are non-controlled substances. DEA telehealth rules don’t apply to these. You can prescribe them via telehealth just like you would in person, with no federal restrictions beyond standard of care.

Where DEA rules matter:

• Adjunct stimulants (e.g., Adderall for treatment-resistant depression or co-occurring ADHD) – Schedule II
• Benzodiazepines for anxiety or insomnia in depressed patients – Schedule IV
• Esketamine (Spravato) for treatment-resistant depression – Schedule III (requires REMS certification and in-office administration, but evaluation can be via telehealth)

If you’re managing depression without controlled substances, federal telehealth rules are a non-issue. But if your practice includes ADHD, anxiety, or complex cases requiring augmentation strategies, the DEA rules apply—and right now, they’re in your favor.

Scope of Practice: Psychiatrists vs PMHNPs

Psychiatrists (MD/DO)

Full prescriptive authority in all states. No supervision required. You can diagnose, treat, and prescribe any medication for depression (including Schedule II controlled substances) via telehealth, as long as you’re licensed in the patient’s state and following DEA rules.

Psychiatric Mental Health Nurse Practitioners (PMHNPs)

Your scope depends on state law—and it varies dramatically.

Full Practice Authority States:

• California (as of 2024, via AB 890): Experienced PMHNPs (3+ years) can practice independently, including prescribing controlled substances.
• New York (as of 2022): PMHNPs with 3,600+ hours of experience can practice without physician collaboration.
• Illinois: APRNs with Full Practice Authority (FPA) after 4,000 hours can prescribe independently, including Schedule II drugs (with consultation requirements for long-term opioids).

Collaboration Required:

• Texas: PMHNPs must have a prescriptive authority agreement with a physician. Monthly meetings and oversight required.
• Florida: Psychiatric NPs are excluded from autonomous practice. You need a supervising physician and signed protocol.
• Pennsylvania: Collaborative agreement with a physician required for prescribing.

What this means for your practice:If you’re a PMHNP in a full-practice state, you can join a telehealth platform and manage depression patients independently. In a restricted state, you’ll need a collaborating psychiatrist on paper—which could mean additional administrative setup but also opportunities for psychiatrists to supervise NP teams.

State-by-State Telehealth Prescribing Rules

California

• NP independence: Yes (for experienced PMHNPs as of 2024)
• Telehealth prescribing: No state law requiring in-person exams. Telehealth held to same standard as in-person.
• Controlled substances: Follow federal DEA rules. No additional state restrictions for psychiatric prescribing.
• Licensing: Must hold CA license. California is not in the Interstate Medical Licensure Compact—out-of-state providers need a full license.

Reality check: California is permissive and has robust telehealth infrastructure. But getting licensed here is more involved than in compact states. Once you’re in, you can practice telepsychiatry with minimal friction.

Texas

• NP independence: No. Prescriptive authority agreement with a physician required.
• Telehealth prescribing: Valid patient relationship can be established via video. Chronic pain treatment with controlled substances via telehealth is prohibited (except under strict conditions)—but this doesn’t limit psychiatric prescribing for depression, anxiety, or ADHD.
• Controlled substances: No state ban on psychiatric meds via telehealth. Just ensure video evaluation for new patients.
• Licensing: Must have TX license. Texas is in the IMLC (Interstate Medical Licensure Compact), making multi-state licensing easier for MDs.

Reality check: Texas has a massive need for telepsychiatry—246 of 254 counties are mental health shortage areas. But NP supervision requirements add administrative complexity. Psychiatrists have clear authority; PMHNPs need a collaborative physician.

Florida

• NP independence: No—psychiatric NPs are excluded from autonomous practice. Supervision required.
• Telehealth prescribing: Florida allows out-of-state providers to register for telehealth practice. Key rule: Schedule II controlled substances can only be prescribed via telehealth for psychiatric disorders, inpatient care, hospice, or nursing home patients.
• Controlled substances: The psychiatric exception means you can prescribe Adderall, Ritalin, etc., via telehealth for depression or ADHD—just document the psychiatric diagnosis clearly.
• Licensing: Full FL license or out-of-state telehealth registration. Florida is in the IMLC.

Reality check: Florida’s telehealth registration is a huge opportunity—you can reach FL patients without relocating. The Schedule II exception for psychiatric disorders is explicitly provider-friendly. But ensure your documentation reflects psychiatric treatment to stay compliant.

New York

• NP independence: Yes (after 3,600 hours of experience, no written collaboration required).
• Telehealth prescribing: No state restrictions. Audio-only allowed for mental health in some cases (especially during COVID extensions).
• Controlled substances: Follow federal DEA rules. No additional state barriers.
• Licensing: Must have NY license. Not in IMLC.

Reality check: New York embraced telepsychiatry early and has strong parity laws. Experienced PMHNPs can practice independently. Getting licensed in NY takes time, but once you’re in, the regulatory environment is supportive.

Pennsylvania

• NP independence: No. Collaborative agreement required.
• Telehealth prescribing: No permanent state telehealth law, but state guidance confirms telehealth is permissible if it meets standard of care. Mandatory e-prescribing for controlled substances.
• Controlled substances: Follow federal rules. No state-specific telehealth ban.
• Licensing: Must have PA license. Pennsylvania is in the IMLC as of 2021.

Reality check: PA has significant rural provider shortages, making telepsychiatry essential. Regulatory uncertainty (no formal telehealth statute) means you rely on board guidance—stay conservative with documentation and informed consent.

Illinois

• NP independence: Yes, via Full Practice Authority (FPA) after 4,000 hours + additional training.
• Telehealth prescribing: Strong telehealth parity law (2021). No in-person exam mandate. Audio-only allowed for behavioral health.
• Controlled substances: FPA APRNs can prescribe Schedule II–V. Consultation with a physician required for long-term Schedule II opioid prescriptions.
• Licensing: Must have IL license. Illinois is in the IMLC for physicians.

Reality check: Illinois is one of the most progressive states for NP practice and telehealth. If you’re a PMHNP with FPA, you can operate independently on a telehealth platform with minimal administrative burden.

State Comparison: Quick Reference Table

The Economics of Telehealth Prescribing: Why Platforms Like Klarity Make Sense

Let’s talk money.

Building a telehealth practice from scratch sounds appealing—until you run the numbers on patient acquisition.

The Real Cost of DIY Marketing

SEO: Takes 6–12 months of consistent investment before generating meaningful patient flow. Most solo providers don’t have the expertise or patience.

Google Ads: Mental health keywords cost $15–40+ per click. Most clicks don’t convert to booked patients. Realistic cost per booked patient: $200–400+.

Directory Listings (Psychology Today, Zocdoc): Monthly fees plus per-booking charges ($35–100+ on Zocdoc). You’re competing with hundreds of other providers on the same page.

Agency/Consultant Fees: If you hire help, add $2,000–5,000/month in retainer fees.

Total monthly spend for uncertain results: $3,000–5,000+. And that’s before factoring in no-show rates, failed campaigns, and the opportunity cost of your time managing all this instead of seeing patients.

The Platform Model: Pay-Per-Appointment

Klarity Health uses a pay-per-appointment model. You pay a standard listing fee per new patient lead—only when a qualified patient books with you.

No upfront marketing spend. No monthly subscriptions. No wasted ad spend.

You get:

• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• Full control over your schedule

The economic reality: Instead of gambling $3,000–5,000/month on marketing with uncertain ROI, you pay only when you see patients. That’s guaranteed ROI vs. DIY marketing risk.

DIY marketing can eventually be cost-effective—if you have the budget, expertise, and patience. For most providers, especially those starting out or scaling, a platform that handles patient acquisition removes the risk entirely.

Practical Compliance Checklist

Before Your First Telehealth Visit:

• [ ] Confirm you’re licensed in the patient’s state
• [ ] Verify your DEA registration is active in that state
• [ ] Ensure your e-prescribing system is DEA-compliant for controlled substances
• [ ] Register for the state’s Prescription Drug Monitoring Program (PDMP)
• [ ] Draft informed consent language specific to telehealth (include emergency protocols)

During the Visit:

• [ ] Verify patient identity and location
• [ ] Document that you’ve established a valid provider-patient relationship
• [ ] Conduct a thorough psychiatric evaluation (same standard as in-person)
• [ ] Check the PDMP before prescribing controlled substances
• [ ] Document clinical rationale for any controlled substance prescriptions

After the Visit:

• [ ] Use e-prescribing for all medications (required in most states)
• [ ] Document emergency contact info and local crisis resources for the patient
• [ ] Schedule follow-up within clinically appropriate timeframe

What’s Coming: Staying Ahead of Regulatory Changes

Monitor DEA announcements through 2026. The special telemedicine registration system will likely launch before the December 2026 extension expires. If you’re a psychiatrist prescribing Schedule II drugs, you’ll probably need to apply for this registration.

State laws are trending toward NP independence. If you’re a PMHNP in a restricted state, keep an eye on legislation—Pennsylvania, Texas, and others regularly introduce bills to expand scope of practice.

Telehealth parity is solidifying. Most states now require insurers to cover telehealth at the same rate as in-person. This trend is expanding, not contracting.

Platform regulation is increasing. The DEA’s focus on registering telehealth companies means platforms will face more scrutiny. Choose partners (like Klarity) that prioritize compliance and transparency.

The Bottom Line

Can psychiatrists prescribe medication via telehealth? Yes—and the regulatory environment is moving in your favor.

Can PMHNPs? Yes, but it depends on your state. If you’re in a full-practice state (CA, NY, IL), you have the same prescriptive authority as in person. In restricted states, you’ll need a collaborating physician.

Can you prescribe controlled substances? Yes, through December 31, 2026, under the DEA’s extended COVID-era flexibilities. After that, you’ll likely need a special registration, but the rules are being written to accommodate psychiatric practice.

Should you build your own telehealth practice or join a platform? If you have $3,000–5,000/month to burn on uncertain marketing results and 6–12 months to wait for SEO to kick in, go DIY. If you want pre-qualified patients, guaranteed ROI, and no upfront marketing spend, a platform like Klarity is the smarter economic choice.

Ready to Expand Your Depression Treatment Practice?

Klarity Health connects psychiatrists and PMHNPs with patients actively seeking medication management for depression, anxiety, ADHD, and other mental health conditions. No marketing budget required. No subscription fees. Just qualified patients matched to your schedule.

Explore Klarity’s provider network and see how telehealth prescribing can grow your practice—without the risk of traditional marketing.

FAQ

Can I prescribe antidepressants via telehealth if I’ve never met the patient in person?

Yes. Non-controlled antidepressants (SSRIs, SNRIs, bupropion, etc.) have no federal in-person requirement. As long as you conduct a proper evaluation via video and meet your state’s standard of care, you can prescribe.

Can I prescribe Adderall or benzodiazepines via telehealth?

Yes, through December 2026, under the DEA’s temporary extension. After that, psychiatrists will likely need a special telemedicine registration to continue prescribing Schedule II drugs via telehealth. Standard evaluation and documentation requirements apply.

Do I need a separate DEA registration for telehealth prescribing?

Not yet. Under current rules (through 2026), you use your existing DEA registration. Starting in 2027 (pending finalization of DEA rules), you may need to apply for a ‘Special Registration for Telemedicine’ to continue prescribing controlled substances via telehealth.

Can PMHNPs prescribe independently via telehealth?

It depends on your state. California (after 2024), New York, and Illinois allow experienced PMHNPs to practice independently. Texas, Florida, and Pennsylvania require a collaborating physician.

What if I’m licensed in one state but want to treat patients in another?

You need a license (or telehealth registration) in the patient’s state. Some states (like Florida) offer out-of-state telehealth registration. Others (like California) require a full license. Physicians can use the Interstate Medical Licensure Compact (IMLC) to streamline multi-state licensing.

Can I prescribe via phone-only, or does it have to be video?

Most states require video for establishing a new patient relationship and prescribing, especially for controlled substances. Some states (like New York and Illinois) allowed audio-only for behavioral health during COVID, and those provisions have been extended in some cases. Check your state’s rules—default to video to be safe.

What’s the difference between Klarity and Psychology Today for patient acquisition?

Psychology Today is a directory listing. You pay a monthly subscription ($30–50/month) and compete with hundreds of other providers on search results. Patients may or may not book—and when they do, they’re often shopping around. Klarity is a pay-per-appointment platform. You only pay when a pre-qualified patient books with you, and the platform handles patient acquisition, credentialing, and telehealth infrastructure. ROI comparison: Directory listings give you exposure; Klarity gives you patients.

How much does it cost to acquire a psychiatric patient through DIY marketing?

Realistically, $200–500+ per qualified patient when you factor in ad spend, agency fees, testing/optimization, no-show rates, and months of SEO investment. Google Ads alone for mental health keywords can run $15–40+ per click, with conversion rates often under 5%. A platform like Klarity removes that variable cost and gives you predictable economics.

Citations & Sources

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026’ (January 2, 2026): www.hhs.gov

2. DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Care’ (January 16, 2025): www.dea.gov

3. Florida Statutes §456.47 – Use of Telehealth to Provide Services (2019, updated through 2025): www.leg.state.fl.us

4. Texas Administrative Code Title 22, Part 9 §174.5 – Telemedicine Issuance of Prescriptions (updated January 15, 2025): txrules.elaws.us

5. California AB 890 Implementation – CA Board of Registered Nursing (updated January 2023): www.rn.ca.gov

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service